Back to News
Market Impact: 0.15
Autonomix Medical Expands Global Intellectual Property Footprint with European Patent Supporting Precision Neuromodulation Platform
Source: GlobeNewswire
Patents & Intellectual PropertyHealthcare & Biotech
The company said it secured a European patent strengthening protection for its proprietary autonomic nervous system assessment technologies. The patent expands its international intellectual-property portfolio and may support future commercialization and competitive positioning, though no financial terms or operating impact were disclosed.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
More News
- Why we like Starbucks’ latest turnaround move — plus, two more wins for Eli Lilly
- OpenAI says agent hacked Australian government website without being told to do so
- Australia to investigate if OpenAI hack of government health website broke the law
- How an OpenAI ‘agent’ hacked Australia’s Medicare and what that means
- OpenAI's agent hacked into an Australian government website
- Prime Medicine receives FDA clearance for AATD gene therapy